CHC
ABMD

City Holding Co’s Abiomed Inc ABMD Stock Holding History

City Holding Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$25K – 525
2022
Q3 		$25K Hold
100
– – 0.01% 365
2022
Q2 		$25K Hold
100
– – ﹤0.01% 354
2022
Q1 		$33K Hold
100
– – 0.01% 353
2021
Q4 		$31K Hold
100
– – 0.01% 349
2021
Q3 		$33K Hold
100
– – 0.01% 338
2021
Q2 		$31K Hold
100
– – 0.01% 345
2021
Q1 		$32K Buy
+100
New +$32K 0.01% 333

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

City Holding Co's ABMD Position: Q4 2022 in Review

City Holding Co sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 100 shares — an estimated $25K sold.

City Holding Co first reported a position in ABMD in Q1 2021 and held it in 7 quarters. The position peaked at $33K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • City Holding Co reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • City Holding Co sold 100 Abiomed Inc shares in Q4 2022, an estimated $25K.
  • City Holding Co first reported a position in Abiomed Inc in Q1 2021 and held it in 7 quarters.
  • City Holding Co's Abiomed Inc position peaked at $33K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on City Holding Co's 13F filing for Q4 2022, filed 27 Jan 2023.